Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript

HRMY earnings call for the period ending June 30, 2023.

Related Keywords

, Jeff Dierks , Charles Duncan , David Amsellem Piper Sandler , Poorna Kannan Needham , Corinne Jenkins Goldman Sachs , Francois Brisebois , Corinne Jenkins , Charles Duncan Cantor Fitzgerald , Kumar Budur , Jeffrey Dayno , Graig Suvannavejh Mizuho , Piper Sandler , David Amsellem , Danielle Brill , Luis Sanay , Raymond James , Alex Nackenoff Raymond James , America Merrill Lynch , Jeffrey Dierks , Francois Brisebois Oppenheimer , Graig Suvannavejh , Jason Gerberry , Sandip Kapadia , Jeff Dayno , Jason Gerberry Bank , Symphony Health , Cantor Fitzgerald , Company Analyst , Needham Company , Goldman Sachs , Harmony Biosciences , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Ami Fadia , Scorpion Capital ,